Literature DB >> 2358675

Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.

R D Schneiderman1, T F Lint, K L Knight.   

Abstract

Previous experiments have resulted in the identification and cloning of 13 nonallelic genes encoding the constant region of rabbit IgA H chains. The genes, C alpha 1 to C alpha 13, were each cloned into an expression vector containing the VDJ gene of a dansyl (DNS)-binding murine hybridoma and the constructs were then transfected into SP2/0 cells that were producing murine kappa-L chains from the DNS-binding hybridoma. Of the 13 resulting transfectomas, 12 were shown, by ELISA, to secrete DNS-binding chimeric rabbit-mouse IgA molecules. These transfectoma antibodies, representing 12 different isotypes, are of high affinity and provide a unique source of Ag-specific IgA for comparison of the functions of the multiple IgA isotypes. One such function for antibodies is activation of C by either the classical or alternative pathway. We have used the DNS-binding IgA transfectoma antibodies in C assays based on binding of rabbit C3 to IgA-Ag complexes in an ELISA. The results demonstrated that all 12 IgA isotypes are capable of activating C by the alternative pathway but that none can activate C by the classical pathway. Control experiments demonstrated that activation was hapten dependent and was not caused by endotoxin contamination. These data demonstrate that Ag-specific IgA molecules, unmodified by heat or chemical aggregation, activate C by the alternative pathway but not by the classical pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.

Authors:  Claudine E Fasching; Tracy Grossman; Blaise Corthésy; Andrew G Plaut; Jeffrey N Weiser; Edward N Janoff
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

2.  Molecular characterization of complement components (C3, C4, and factor B) in human saliva.

Authors:  A Andoh; Y Fujiyama; T Kimura; H Uchihara; H Sakumoto; H Okabe; T Bamba
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas.

Authors:  K Sumiyoshi; A Andoh; Y Fujiyama; H Sakumoto; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

4.  Recombinant human IgA expressed in insect cells.

Authors:  L Carayannopoulos; E E Max; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Characterization of complement C3, C4, and factor B molecules in human bile.

Authors:  K Sumiyoshi; A Andoh; Y Fujiyama; H Sakumoto; T Bamba
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

6.  Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas.

Authors:  A Andoh; Y Fujiyama; H Sakumoto; H Uchihara; T Kimura; S Koyama; T Bamba
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  In vivo activation of complement by IgA in a rat model.

Authors:  R K Stad; W M Bogers; M E Thoomes-van der Sluys; L A Van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.